Fukutin-related protein

FKRP
Identifiers
AliasesFKRP, LGMD2I, MDC1C, MDDGA5, MDDGB5, MDDGC5, fukutin related protein, LGMDR9, FKTR
External IDsOMIM: 606596; MGI: 2447586; HomoloGene: 11513; GeneCards: FKRP; OMA:FKRP - orthologs
Orthologs
SpeciesHumanMouse
Entrez

79147

243853

Ensembl

ENSG00000181027

ENSMUSG00000048920

UniProt

Q9H9S5

Q8CG64

RefSeq (mRNA)

NM_001039885
NM_024301

NM_173430
NM_001358846

RefSeq (protein)

NP_001034974
NP_077277

NP_775606
NP_001345775

Location (UCSC)Chr 19: 46.75 – 46.78 MbChr 7: 16.54 – 16.55 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Fukutin-related protein (FKRP) is also known as FKRP_HUMAN, LGMD2I, MDC1C, MDDGA5, MDDGB5, and MDDGC5. FKRP can be located in the brain, cardiac muscle and skeletal muscle, and in cells it is found in the Golgi apparatus. Fukutin is expressed in the mammalian retina and is located in the Golgi complex of retinal neurons.

The genomic location of the FKRP gene is on chromosome 19. FKRP is a ribitol-5-phosphate (enzyme) glycosyltranferase, which means this enzyme helps create glycosidic linkages to an acceptor. In glycosylation of α-dystroglycan (sugar chain) it adds a ribitol-5-phosphate onto the M3 core O-mannosylation of α-dystroglycan to create O-linked mannosylation. Without this linkage α-dystroglycan will not function properly, this can cause issues with the cytoskeleton, and extracellular matrix. In skeletal muscles the α-dystroglycan helps stabilize and protect muscle fibers, in the brain it directs movement of nerve cells. This could be caused by mutations that binds ribitol-5-phosphate to the α-dystroglycan incorrectly. These mutations have been found to be associated with congenital muscular dystrophy, dystroglycanopathies, and Walker-Warburg syndrome. The severity of these diseases are correlated to the amount of mutations occurring. Possible therapy options for FKRP mutations include small molecules, gene delivery, and cell therapy.